Search PubMed⌕ Search

Biomedical subjects

M Block

Publications and source records attributed to M Block.

At least 109 records · Page 6Linked to original sources
PubMed1992

Role of ventricular tachycardia surgery and catheter ablation as complements or alternatives to the implantable cardioverter defibrillator in the 1990s.

Although the implantable cardioverter defibrillator is used increasingly, other nonpharmacological approaches have their indications and merits. Furthermore, as the natural history of ventricular tachyarrhythmias or their underlying structural cardiac abnormality, i.e., coronary artery disease, dilated cardiomyopathy, arrhythmogenic right ventricular disease, etc. change, the mode of therapy may be modified accordingly. Because of the disappointing results of the CAST study in previously asymptomatic patients after myocardial infarction and the evidence that failure of one or two antiarrhythmic drugs tested by programmed ventricular stimulation in patients with documented sustained ventricular tachycardia or fibrillation predicts further drug failure, there will be a significant increase in the use of implantable cardioverters defibrillators in the 1990s. However, care should be taken to avoid inappropriate use of these devices.

Adult↗
PubMed1992

Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants.

BACKGROUND: Third-generation implantable cardioverter-defibrillators are devices designed to treat ventricular tachycardia (VT) and ventricular fibrillation (VF) by means of overdrive pacing, cardioversion, or defibrillation. So far, the efficacy of tiered therapy has been documented only in small series. Therefore, a European multicenter clinical evaluation study of a new tachyarrhythmia control device, the Medtronic PCD pacer-cardioverter-defibrillator with epicardial patch-lead configuration, was undertaken. METHODS AND RESULTS: We report on 102 patients (mean age, 55 +/- 13 years) from 11 European centers. PCD devices implanted between May 1989 and February 1991 were included. The patients suffered from hemodynamically significant ventricular tachyarrhythmias not suppressed by antiarrhythmic drug therapy and unrelated to acute myocardial infarction; one patient had nonsustained VT and severely depressed left ventricular function. Seventy patients had coronary artery disease with old myocardial infarctions, 23 had cardiomyopathies of various etiologies, and nine patients had no detectable heart disease. Mean ejection fraction was 36 +/- 14% (range, 10-76%). Mean intraoperative defibrillation threshold (51 patients) was 10.6 +/- 5.1 J (range, 2-18 J). The documented follow-up ranged from 1 to 21 months (mean, 9.4 +/- 5.8 months), or 79.9 cumulative patient-years. Perioperative mortality was 3.9%. The actuarial survival rate at 12 months was 91%. One sudden arrhythmic death occurred. Sixty patients (58%) received device therapy. Seventeen patients had therapies only for "VF" episodes, 16 patients only for VT, and 28 patients for VT and "VF" episodes. Based on device memory data, 1,235 spontaneous VT episodes were detected and treated in 43 patients. Twelve hundred four of these VT episodes received painless initial antitachycardia pacing therapy, restoring sinus rhythm in 91%. The 108 ongoing episodes received 209 multiple therapeutic attempts. Eighty-five additional overdrive pacing therapies restored sinus rhythm in 30%. Initial ineffective antitachycardia pacing therapies received 51 cardioversion pulses. The success rate was 61%. Seventy-three additional cardioversion pulses were delivered to backup ineffective pacing therapy as well as ineffective secondary cardioversion pulses. Their success rate was only 40%. Two hundred eighty-six spontaneous episodes were detected in 44 patients as "VF." Overall defibrillation efficacy was 97.6%. CONCLUSIONS: The implanted device nearly eliminates sudden arrhythmic death in patients with documented, potentially fatal ventricular tachyarrhythmias. Automatic tiered therapy is highly effective to restore sinus rhythm, provided that an integrated two-zone tachycardia detection algorithm is used, assigning lower tachycardia rates to overdrive pacing and/or cardioversion and higher tachycardia rates to defibrillation. In general, spontaneous VTs can be terminated by automatic overdrive pacing, and painful or disturbing countershock therapies are not required to terminate the majority of spontaneous VT episodes.

Death, Sudden, Cardiac↗
PubMed1992

[Percutaneous high frequency current catheter ablation in permanent ventricular tachycardia of the "bundle-branch reentry" type after implantation of an automatic cardioverter-defibrillator].

A 65-year-old female patient with a history of recurrent sustained ventricular tachycardia presented with an incessant ventricular tachycardia (cycle length 360-400 ms) following implantation of a cardioverter-defibrillator (ICD). The tachycardia could not be terminated by antiarrhythmic drug treatment, antitachycardia pacing or internal defibrillation via the ICD. An invasive electrophysiologic study revealed that the mechanism of this newly occurring tachycardia was bundle branch reentry. The patient underwent emergency catheter ablation using radiofrequency (RF) current. Endocardial mapping of the right bundle branch and of the distal His bundle was performed and a bundle branch reentry tachycardia was diagnosed. After delivery of the fifth RF-impulse, the tachycardia terminated and complete AV block was induced. No malfunction of the ICD was observed following RF-ablation. The patient was hemodynamically stable with a junctional escape rhythm and antibradycardia pacing back-up of the ICD (VVI-mode). This case report demonstrates the feasibility of RF catheter ablation in the treatment of incessant bundle branch reentry tachycardia as a complementary option after implantation of an ICD.

Aged↗
PubMed1991

Ultrastructural abnormalities of mitochondria and deficiency of myocardial cytochrome c oxidase in a patient with ventricular tachycardia.

A 30-year-old woman presented with life-threatening ventricular tachycardia without overt heart disease. Ultrastructural investigation of endomyocardial biopsy disclosed abnormally structured and often enlarged mitochondria. Morphometry revealed the ratio of volume density of mitochondria to myofibrils to be markedly increased to 0.667 as compared with five controls (mean: 0.46; range: 0.445-0.479). Investigation of mitochondrial respiratory chain enzymes revealed a 90% reduction in activity of cytochrome c oxidase. Our data suggest that mitochondrial cardiomyopathy may induce malignant ventricular arrhythmias.

Adult↗
PubMed1991

Decreased norepinephrine and epinephrine contents in chromaffin tissue of rainbow trout (Oncorhynchus mykiss) exposed to diethyldithiocarbamate and amylxanthate.

1. Rainbow trout (Oncorhynchus mykiss) were exposed to 0.5 or 5.0 microM of diethyldithiocarbamate (DDC) or amylxanthate (AX) for 24 hr. 2. Both DDC (0.5-5.0 microM) and AX (5.0 microM) significantly decreased norepinephrine and epinephrine levels in the head kidney as well as the quotients epinephrine/dopamine and/or norepinephrine/dopamine. 3. The results probably reflect an inhibition of dopamine-beta-hydroxylase, the enzyme responsible for the synthesis of norepinephrine and epinephrine from dopamine. 4. It is concluded that an exposure of fish to these complexing agents could disturb physiological processes controlled by catecholamines. 5. Diethyldithiocarbamate may prove to be a valuable pharmacological tool for the study of catecholamine function in fish.

Animals↗
PubMed1991

Implantable cardioverter/defibrillators (ICD): a new lead-system using transvenous-subcutaneous approach in patients with prior cardiac surgery.

The current approach in cardioverter-defibrillator implantation requires placement of epicardial leads which may lead to pericardial and/or pleural effusion and pneumonia during the perioperative period. Although ICD implantation is less invasive than other surgical techniques for the treatment of rhythm disturbances, the perioperative mortality must be considered. Minimizing the operative procedure could lead to a reduction in perioperative mortality. Therefore, we investigated an approach without the need for thoracotomy using a transvenous/subcutaneous lead system. In nine patients with prior cardiac surgery, defibrillator implantation was performed by a transvenous/subcutaneous approach. There was no perioperative mortality. In all patients, a sufficient defibrillation threshold was achieved. The defibrillation pulses were delivered as two sequential pulses between a right ventricular electrode (cathode) and a coronary sinus or superior caval vein electrode (anode 1) and a subcutaneous patch electrode (anode 2). Intubation of the coronary sinus was necessary in 4 patients in order to obtain satisfactory defibrillation thresholds. These data demonstrate that a transvenous/subcutaneous approach is feasible in patients with prior cardiac surgery obviating the need for thoracotomy. Sensing function of the RV-electrode, intubation of the coronary sinus and the intraoperative use of an epicutaneous patch electrode are current problems of this new technique.

Adult↗
PubMed1991

Smoking-cessation treatment combining transdermal nicotine substitution with behavioral therapy.

Effects of smoking-cessation treatment combining transdermal nicotine substitution with behavioral therapy were investigated in two studies. A total of 403 smokers underwent nine weeks of behavioral self-control treatment. For seven weeks, groups with transdermal nicotine substitution were also provided with nicotine patches that continuously release nicotine through the skin into the circulatory system. The effects of treatment were measured by total abstinence. The results showed that the nicotine concentration in the patch, special relapse prevention methods, and the type of dosage (individual versus fixed dose) had no influence on therapeutic success. Nicotine concentration played a decisive role in the compatibility of the patch. Combining transdermal nicotine substitution with behavioral therapy produced 12-month success rates (total abstinence) of about 35%.

Administration, Cutaneous↗
PubMed1991

Cardiopulmonary effects of internal cardioverter/defibrillator implantation.

Cardiopulmonary effects of electrophysiological testing of internal cardioverter/defibrillator (ICD) devices were studied in ten patients undergoing general anaesthesia. In the control-phase, haemodynamic performance and oxygenation were slightly impaired. After completion of the electrophysiological procedures (ICD-phase), cardiopulmonary function had deteriorated significantly. Cardiac index declined by 16%, whereas left ventricular filling pressure and pulmonary vascular resistance increased (P less than or equal to 0.01). Oxygenation, but not CO2-elimination deteriorated (P less than or equal to 0.01) and venous admixture increased by 72% (P less than or equal to 0.01). Alveolo-arterial PO2-difference (PA-aO2) increased by 43% (P less than or equal to 0.01), indicating ventilation-perfusion (VA/Q) mismatching. Repeated inductions of ventricular tachycardia and/or fibrillation subject the myocardium to transient global ischaemia, leading to acute congestive heart failure, and positive inotropic intervention was necessary in 40% of the patients. Partial pulmonary insufficiency resulted possibly from interstitial oedema and VA/Q-inhomogeneities. ICD implantation has detrimental effects on haemodynamics and gas exchange in patients with impaired left ventricular function.

Aged↗
PubMed1991

[Initial clinical experiences with a transvenous-subcutaneous defibrillation system].

In 19 patients with an indication for an implantable defibrillator, it was tried to avoid thoracotomy by using two electrodes positioned via the subclavian vein in the right ventricle (for pacing, sensing, and defibrillation) and the superior vena cava or coronary sinus (for defibrillation), and one electrode positioned subcutaneously near the ventricular apex (for defibrillation). In 17 patients (89%) the transvenous-subcutaneous leads were implanted, whereas in the remaining two patients an epi-/pericardial lead system was subsequently used due to an insufficient defibrillation threshold. Perioperatively, no major complications were observed and patients were rapidly mobilized. Within a follow-up period of 7 +/- 4 months, no malfunction of the lead system became evident. Sixty-eight episodes of spontaneous ventricular tachyarrhythmias occurred, all of which were successfully terminated. In one patient an infection of the lead system developed after 2 months that proved refractory to antibiotics and required surgical removal. Thus, transvenous-subcutaneous placement of leads for implantable defibrillators yielded a sufficient defibrillation threshold in the majority of patients. Long-term efficacy was excellent and no malfunctions were observed. This approach seems to be feasible and advisable in patients with an increased risk for thoracotomy.

Adolescent↗
PubMed1990

Envelope membranes from mature spinach chloroplasts contain a NADPH:protochlorophyllide reductase on the cytosolic side of the outer membrane.

Using fluorescence spectroscopy, we have demonstrated that isolated envelope membranes from mature spinach chloroplasts catalyze the phototransformation of endogenous protochlorophyllide into chlorophyllide in presence of NADPH, but not in presence of NADH. Protochlorophyllide reductase was characterized further using monospecific antibodies (anti-protochlorophyllide reductase) raised against the purified enzyme from oat. In mature spinach chloroplasts, protochlorophyllide reductase is present only in envelope membranes. We have demonstrated that the envelope protochlorophyllide reductase, a 37,000-dalton polypeptide, is only a minor envelope component and is present on the outer surface of the outer envelope membrane. This conclusion is supported by several lines of evidence: (a) the envelope polypeptide that was immunodecorated with anti-protochlorophyllide reductase can be distinguished from the major 37,000-dalton envelope polypeptide E37 (which was identified by monospecific antibodies) only after two-dimensional polyacrylamide gel electrophoresis; (b) the envelope protochlorophyllide reductase was hydrolyzed when isolated intact chloroplasts were incubated in presence of thermolysin; and (c) isolated intact chloroplasts strongly agglutinate when incubated in presence of antibodies raised against protochlorophyllide reductase. These results demonstrate that major differences exist between chloroplasts and etioplasts with respect to protochlorophyllide reductase levels and localization. The presence on the chloroplast envelope membrane of both the substrate (protochlorophyllide) and the enzyme (protochlorophyllide reductase) necessary for chlorophyllide synthesis could have major implications for the understanding of chlorophyll biosynthesis in mature chloroplasts.

Chloroplasts↗
PubMed1990

Pulmonary fibrosis associated with low-dose adjuvant methyl-CCNU.

Pulmonary fibrosis is a serious side effect of nitrosourea therapy, occurring most frequently in patients treated with BCNU. Pulmonary fibrosis developed in a 63 year-old male patient while being treated with adjuvant methyl-CCNU for rectal carcinoma. This toxicity is rare with methyl-CCNU, having only been reported once previously. The case of methyl-CCNU-induced pulmonary fibrosis reported here occurred at a much lower total dose than the first reported case (604 mg/m2 vs. 2,733 mg/m2). Details of the case history, including radiographic and pathologic findings, are presented.

Antineoplastic Combined Chemotherapy Protocols↗
PubMed1990

Primary lymphoma of bone.

Primary lymphoma of bone is a rare clinical entity that accounts for less than one per cent of all non-Hodgkin's lymphomas. Although they occasionally present as a solitary lesion in bone, lymphoma involving bone is a manifestation of disseminated disease in many instances. All patients initially found to have a solitary lymphoma of bone need to be thoroughly investigated for systemic disease because more than half of the patients presenting with initially solitary bone lesions are found to have systemic disease involving lymph nodes and/or other organs. Choice of therapeutic management is based on the stage of disease. Stage I-E primary lymphoma of bone can be controlled in 70-90% of cases using local radiation therapy alone if adequate radiation doses are used. Patients with advanced disease should be treated with combination chemotherapy in addition to local radiotherapy. Loeffler et al reported long-term survival results of 90% 8-year actuarial overall survival rate for children with primary lymphoma of bone who received combined therapy with radiation and chemotherapy (adriamycin, prednisone and oncovin). The actuarial lymphoma-free survival rate was 100% at eight years. Regardless of stage of the disease, radiation treatment to the primary tumor appears to be critical for adequate local control of disease as well as rapid symptomatic relief.

Adult↗
PubMed1990

Falling among the sensorially impaired elderly.

Recent studies of the healthy elderly indicate that accidental falls account for many lengthy hospital stays and permanent disabilities. An ongoing investigation by our group is examining the contribution of neuromuscular feedback and the possible substitution of visual-perceptual feedback as a major contributor to falling in this population. This combination of decreased weighting of neuromuscular factors and increased weighting of the visual-perceptual factors led to the following hypothesis: Those persons who cannot see should show less change in frequency of falling as they age than sighted cohorts. The deaf, who rely more than others on visual perceptual stimuli, are less likely to fall as they age than the general elderly population, who first begin to rely more heavily on visual stimuli when they age. Thus, the deaf and blind constitute a population whose change in frequency of falls with increased age should differ markedly from change in the frequency of falls among the nonblind and nondeaf segments of the population. Our results support the hypothesis. The blind demonstrated a higher rate of falls than the deaf or nonimpaired population. However, the more elderly blind failed to show the increase in falling demonstrated by the deaf and nonimpaired. If these findings are confirmed in subsequent studies, the nonimpaired and deaf elderly could be trained to focus on visual feedback. The blind may be able to reduce the frequency of falls by enhancing musculoskeletal feedback and strength via exercise.

Accidental Falls↗
PubMed1989

[The reliability of angiographic volume determination of the left ventricle using digital image subtraction--significance in stress tests].

Using the technique of digital subtraction angiography (DSA), left ventricular volumes can be determined after intravenous injection of contrast medium at rest and during exercise. The significance of the well known errors of angiographic determination of left ventricular volumes was investigated in 22 patients before and during a bicycle exercise test. Before and after exercise 40 ml of contrast medium were injected (18 ml/s) intravenously to calculate left ventricular volumes. Enddiastolic and endsystolic contours of the left ventricle were traced by two investigators (A and B) on five different days. Using these contours, volumes were calculated by a computer system. The first calculation of both investigators (single measurement) and the mean value of all five calculations (repetitive measurements) were compared. In the same procedure left ventricular contours of six patients were calculated after conventional contrast ventriculography (40 ml of contrast medium). No systematic deviations were found in comparing the results of both investigators using the single or repetitive method by means of DSA: (VolB = 0.86 VolA + 12.2, r = 0.97 versus VolB = 0.96 VolA + 9.1, r = 0.99). Compared to single method the residuals (Syx) of the repetitive method were significantly smaller: Syx = +/- 16.3 ml vs +/- 8.9 ml (p less than 0.01). Similar results were found in conventional ventriculography: single method Syx = +/- 18.7 ml and repetitive method Syx = +/- 8.8 ml (p less than 0.01). Comparing the volumes determined by DSA and by conventional ventriculography, respectively, no significant differences were found.(ABSTRACT TRUNCATED AT 250 WORDS)

Angiography↗
PubMed1989

The effect of different dosages of a transdermal nicotine substitution system on the success rate of smoking cessation therapy.

The effectiveness of different nicotine dosages on abstinence rates was investigated in a smoking cessation study. One hundred smokers underwent nine weeks of self-controlled treatment based on behavioral principles. The overall group was divided into two subgroups randomized according to sex, cigarette consumption and age. The first group (n = 51) was given a nicotine dose adapted to daily cigarette consumption. The second group (n = 49) was given a standardized dose. There was, unexpectedly, no difference between the two groups in respect to short-term abstinence rates. These results suggest that standardized dosage is preferred to individually adapted dosage.

Administration, Cutaneous↗